Skip to main content

Together we are beating cancer

Donate now

Lung cancer

Lung cancer is the third most common cancer in the UK, with around 48,500 people diagnosed each year. There are two main types of lung cancer – small cell lung cancer and non small cell lung cancer – depending on how the cells look under the microscope.

The main symptoms are a cough, shortness of breath and weight loss.

Showing 12 out of 350 results
Graphic explaining the IDx trial.

The first participants have taken part in a new research trial that aims to save lives by detecting lung cancer at an earlier stage when it is more treatable. The first participants have taken part in a new research trial that aims to save lives by detecting lung cancer at an earlier stage when it is more treatable.

by Harry Jenkins | News | 16 June 2021

16 June 2021

Lung adenocarcinoma cells
  • Science & Technology
  • Health & Medicine

ASCO 2021 news: follow-up treatments pave the way

One of the biggest meetings of the world’s cancer specialists took place this weekend. Here’s a flavour of the some of the top research presented. One of the biggest meetings of the world’s cancer specialists took place this weekend. Here’s a flavour of the some of the top research presented.

by Harry Jenkins | Analysis | 9 June 2021

9 June 2021

Lung cancer cell

The three latest SMC decisions will provide new treatment options for some adults with non small cell lung cancer, multiple myeloma and a rare type of lymphoma. The three latest SMC decisions will provide new treatment options for some adults with non small cell lung cancer, multiple myeloma and a rare type of lymphoma.

by Cancer Research UK | News | 21 January 2021

21 January 2021

Senedd in Wales.

Confusion over the symptoms of lung cancer and COVID-19 may be responsible for a drop in the number of people being referred for lung cancer tests in Wales. Confusion over the symptoms of lung cancer and COVID-19 may be responsible for a drop in the number of people being referred for lung cancer tests in Wales.

by Cancer Research UK | News | 20 November 2020

20 November 2020

Lung cancer cells under a microscope

The Scottish Medicines Consortium (SMC) has approved 4 new cancer drugs for use on the NHS in Scotland to treat some lung, breast and prostate cancers. The Scottish Medicines Consortium (SMC) has approved 4 new cancer drugs for use on the NHS in Scotland to treat some lung, breast and prostate cancers.

by Cancer Research UK | News | 13 November 2020

13 November 2020

Lung cancer cell

The National Institute for Health and Care Excellence has approved the drug osimertinib to treat some adults in England with untreated, advanced lung cancer. The National Institute for Health and Care Excellence has approved the drug osimertinib to treat some adults in England with untreated, advanced lung cancer.

by Cancer Research UK | News | 11 September 2020

11 September 2020

The National Lung Matrix Trial - a £25 million collaboration with pharmaceutical companies and the NHS - has been exploring how patients with non small cell lung cancer respond to more tailored, targeted treatments. The National Lung Matrix Trial - a £25 million collaboration with pharmaceutical companies and the NHS - has been exploring how patients with non small cell lung cancer respond to more tailored, targeted treatments.

by Alex Lathbridge | Analysis | 15 July 2020

15 July 2020